434 related articles for article (PubMed ID: 19038868)
1. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
[TBL] [Abstract][Full Text] [Related]
2. A new look at the eye: aldosterone and mineralocorticoid receptors as novel targets in retinal vasculopathy.
Touyz RM; Callera GE
Circ Res; 2009 Jan; 104(1):9-11. PubMed ID: 19118282
[No Abstract] [Full Text] [Related]
3. Neovascularization is attenuated with aldosterone synthase inhibition in rats with retinopathy.
Deliyanti D; Miller AG; Tan G; Binger KJ; Samson AL; Wilkinson-Berka JL
Hypertension; 2012 Mar; 59(3):607-13. PubMed ID: 22275532
[TBL] [Abstract][Full Text] [Related]
4. Activation of the aldosterone/mineralocorticoid receptor system and protective effects of mineralocorticoid receptor antagonism in retinal ischemia-reperfusion injury.
Liu Y; Hirooka K; Nishiyama A; Lei B; Nakamura T; Itano T; Fujita T; Zhang J; Shiraga F
Exp Eye Res; 2012 Mar; 96(1):116-23. PubMed ID: 22200488
[TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor antagonism attenuates glomerular filtration barrier remodeling in the transgenic Ren2 rat.
Whaley-Connell A; Habibi J; Wei Y; Gutweiler A; Jellison J; Wiedmeyer CE; Ferrario CM; Sowers JR
Am J Physiol Renal Physiol; 2009 May; 296(5):F1013-22. PubMed ID: 19261739
[TBL] [Abstract][Full Text] [Related]
6. Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.
Tsuji H; Wang W; Sunil J; Shimizu N; Yoshimura K; Uemura H; Peck AB; Khan SR
World J Urol; 2016 Jan; 34(1):89-95. PubMed ID: 25981400
[TBL] [Abstract][Full Text] [Related]
7. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II and aldosterone activate retinal microglia.
Rana I; Suphapimol V; Jerome JR; Talia DM; Deliyanti D; Wilkinson-Berka JL
Exp Eye Res; 2020 Feb; 191():107902. PubMed ID: 31884019
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor antagonism attenuates vascular apoptosis and injury via rescuing protein kinase B activation.
Wei Y; Whaley-Connell AT; Habibi J; Rehmer J; Rehmer N; Patel K; Hayden M; DeMarco V; Ferrario CM; Ibdah JA; Sowers JR
Hypertension; 2009 Feb; 53(2):158-65. PubMed ID: 19114643
[TBL] [Abstract][Full Text] [Related]
10. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
11. Retinal vasculopathy is reduced by dietary salt restriction: involvement of Glia, ENaCα, and the renin-angiotensin-aldosterone system.
Deliyanti D; Armani R; Casely D; Figgett WA; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2033-41. PubMed ID: 25012132
[TBL] [Abstract][Full Text] [Related]
12. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
13. The vasoneuronal effects of AT1 receptor blockade in a rat model of retinopathy of prematurity.
Hatzopoulos KM; Vessey KA; Wilkinson-Berka JL; Fletcher EL
Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3957-70. PubMed ID: 24894399
[TBL] [Abstract][Full Text] [Related]
14. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy.
Downie LE; Pianta MJ; Vingrys AJ; Wilkinson-Berka JL; Fletcher EL
Glia; 2008 Aug; 56(10):1076-90. PubMed ID: 18442090
[TBL] [Abstract][Full Text] [Related]
15. Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb.
Kobayashi N; Fukushima H; Takeshima H; Koguchi W; Mamada Y; Hirata H; Machida Y; Suzuki N; Yokotsuka F; Tabei K; Kobayashi E; Fukuda N; Ishimitsu T
Am J Hypertens; 2010 Sep; 23(9):1007-13. PubMed ID: 20431528
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor.
Dinh QN; Young MJ; Evans MA; Drummond GR; Sobey CG; Chrissobolis S
Brain Res; 2016 Apr; 1637():146-153. PubMed ID: 26923165
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
Hirono Y; Yoshimoto T; Suzuki N; Sugiyama T; Sakurada M; Takai S; Kobayashi N; Shichiri M; Hirata Y
Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
